<DOC>
	<DOCNO>NCT01819194</DOCNO>
	<brief_summary>This trial aim establish correlation patient report comfort use soft contact lenses meibomian gland dysfunction ( MGD ) .</brief_summary>
	<brief_title>Contact Lens Comfort Relative Meibomian Gland Status</brief_title>
	<detailed_description />
	<criteria>1 . The subject must able read , understand , sign statement inform consent receive fully execute copy form . 2 . The subject able willing adhere instruction set forth clinical protocol . 3 . The subject must 18 less 39 year age . 4 . The subject must adapt soft contact lens wearer eye ( Defined full time lens wearer least 3 month ) . 5 . Subjects must current full time daily wearer Acuvue Oasys lenses ( define , least 6 hour per day , 5 day per week ) . 6 . The subject 's spherical equivalent distance refraction must range 0.00 6.00D eye . 7 . The subject must present visit 1 current copy spectacle prescription . 8 . The subject must best correct visual acuity 0.18 good eye assess LogMAR chart . 9 . The subject must normal eye ( i.e. , ocular medication , infection type ) 1 . Wear Acuvue Oasys Hydraclear Plus extend wear basis . 2 . Wear Acuvue Oasys Hydraclear Plus astigmatism . 3 . History epithelial herpes simplex keratitis ( dendritic keratitis ) ; vaccinia , active recent varicella , viral disease cornea and/or conjunctiva ; chronic bacterial disease cornea and/or conjunctiva ; mycobacterial infection eye ; and/or fungal disease eye . 4 . Use concomitant ocular medication study period . Topical artificial tear contact lens lubricant allow , instillation day examination . 5 . Any systemic disease , autoimmune disease , use medication , may interfere contact lens wear . 6 . Subjects use medication influence tear production steroid , immunosuppressive agent and/or anticholinergic ( e.g . cold allergy medication , tricyclic antidepressant ) treatment autoimmune connective tissue disease may enrol study stable dose regimen 30 day prior Eligibility Visit . Subjects may use birth control medication since inconclusive evidence relative influence tear film . 7 . Any infectious disease ( e.g . Hepatitis , tuberculosis ) contagious immunosuppressive disease ( e.g . HIV , self report ) . 8 . Subjects report discomfort screen visit relate fit care system abnormality ( determined investigator ) , ocular condition conjunctival infection , iritis . 9 . Currently pregnant lactating ( subject become pregnant study discontinue ) . 10 . Any ocular systemic allergy disease may interfere contact lens wear . 11 . Entropion , ectropion , extrusion , chalazia , recurrent stye , glaucoma , history recurrent corneal erosion , aphakia , moderate corneal distortion keratometry . 12 . Any previous , plan , ocular intraocular surgery ( radial keratotomy , LASIK , ETC . ) 13 . Any grade 3 great slit lamp finding ( e.g . edema , corneal neovascularization , corneal staining , tarsal abnormality , conjunctival injection ) FDA classification scale , previous history sign contact lensrelated corneal inflammatory event ( e.g . past peripheral ulcer round peripheral scar ) , ocular abnormality may contraindicate contact lens wear . 14 . Any corneal distortion result previous hard rigid gas permeable contact lens wear . 15 . Monovision multifocal contact lens correction 16 . Participation contact lens lens care product clinical trial within 30 day prior study enrollment 17 . History binocular vision abnormality strabismus 18 . History serious mental illness 19 . History seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>